Winton Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-27,761
| Closed | -$443K | – | 979 |
|
|
2021
Q4 | $443K | Sell |
27,761
-32,478
| -54% | -$518K | 0.03% | 706 |
|
|
2021
Q3 | $968K | Sell |
60,239
-16,422
| -21% | -$264K | 0.05% | 522 |
|
|
2021
Q2 | $1.06M | Buy |
76,661
+8,617
| +13% | +$119K | 0.06% | 496 |
|
|
2021
Q1 | $994K | Buy |
68,044
+11,709
| +21% | +$171K | 0.06% | 463 |
|
|
2020
Q4 | $979K | Sell |
56,335
-58,660
| -51% | -$1.02M | 0.07% | 415 |
|
|
2020
Q3 | $2.11M | Buy |
114,995
+63,271
| +122% | +$1.16M | 0.07% | 502 |
|
|
2020
Q2 | $924K | Buy |
+51,724
| New | +$924K | 0.02% | 999 |
|